Parkinson’s Disease Database Analysis of Stereotactic Coordinates Related to Clinical Outcomes

  • Francisco EstellaEmail author
  • Esther Suarez
  • Beatriz Lozano
  • Elena Santamarta
  • Antonio Saiz
  • Fernando Rojas
  • Ignacio Rojas
  • Fernando Seijo
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 10814)


Parkinson’s Disease is one of the leading movement disorder diseases. It is the fourth most common neurological disease, after migraine, stroke and epilepsy. The motor symptoms of the disease significantly impair daily living and quality of life and exact a high burden on both patients and their caregivers. Deep Brain Stimulation is a proven therapy for this disease, getting positive outcomes while reducing medication. In this paper, stereotactic system used for Deep Brain Stimulation (DBS) procedures will be described. Different planning methods will be observed and compared to the gold standard normally used, neurophysiological coordinates recorded intra-operatively. MRI, CT scan and direct calculation of stereotactic coordinates will be compared and group in three different groups, according to DBS therapy outcomes: “very good DBS therapy”, “good DBS therapy” and “not major improvement”.

Database of 72 DBS electrodes implanted in Parkinson’s Disease patients will be studied. Most potentially beneficial ranges of deviation within planning and neurophysiological coordinates from the operating room will be assessed, in order to provide neurosurgeons with more landmarks in order to achieve the best outcomes within a millimetric technique.

We could confirm three main highlights out of this study: the neurophysiological length of the Subthalamic Nucleus does not play a major role in outcomes while being within normal range; CT scan calculations were the most accurate; direct calculations should not be used as major deviations were observed.


Parkinson’s disease Deep brain stimulation Movement disorders Decision tree Stereotactic coordinates 


  1. 1.
    Parkinson’s Disease Foundation. Primary Motor Symptoms. Accessed 25 July 2014
  2. 2.
    European Brain Council. Parkinson’s Disease Fact Sheet 2011.’s%20fact%20sheet%20July%202011.pdf. Accessed 25 July 2014
  3. 3.
    Lasprilla, J.C.A., Fernández Guinea, S., Ardila, A.: Las demencias. ASpectos clínicos, neuropsicológicos y tratamiento. Manual ModernoGoogle Scholar
  4. 4.
    Lutz, W.: European Demographic Data Sheet 2006 (Vienna and Washington, DC: Vienna Institute of Demography, International Institute for Applied Systems Analysis, and Population Reference Bureau) (2006)Google Scholar
  5. 5.
    Dillon, A.: Deep brain stimulation for Parkinson’s disease, National Institute for Clinical Excellence (IPG019), November 2003Google Scholar
  6. 6.
    Fisman, G.K., Herzog, J., Fisman, D., Lang, A.E., Deuschl, G.: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 21(Suppl. 14), S290–S304 (2006)CrossRefGoogle Scholar
  7. 7.
    Deuschl, G., Schade-Brittinger, C., et al.: A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med. 355, 896–908 (2006)CrossRefGoogle Scholar
  8. 8.
    Follett, K.A., Weaver, F.M., Stern, M., et al.: Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med. 362, 2077–2091 (2010)CrossRefGoogle Scholar
  9. 9.
    Fraix, V., Houeto, J.L., Lagrange, C., et al.: Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 77, 443–449 (2006)CrossRefGoogle Scholar
  10. 10.
    Rodriguez-Oroz, M.C.: Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128, 2240–2249 (2005)CrossRefGoogle Scholar
  11. 11.
    Gervais-Bernard, H., Xie-Brustolin, J., Mertens, P., et al.: Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J. Neurol. 256, 225–233 (2009)CrossRefGoogle Scholar
  12. 12.
    Lafaucheur, J.P., Gurruchaga, J.M., Pollin, B., et al.: Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson’s disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia. Eur. Neurol. 60, 186–199 (2008)CrossRefGoogle Scholar
  13. 13.
    Moro, E., Lozano, A., Pollak, P., et al.: Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov. Disord. 25(5), 578–586 (2010)CrossRefGoogle Scholar
  14. 14.
    Tir, M.: Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of Parkinson’s patients. Neurosurgery 61, 297–305 (2007)CrossRefGoogle Scholar
  15. 15.
    Zangaglia, R., et al.: Deep brain stimulation and cognitive functions in Parkinson’s disease: a three-year controlled study. Mov. Disord. 24(11), 1621–1628 (2009)CrossRefGoogle Scholar
  16. 16.
    Timmermann, L., Seijo, F., et al.: Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson’s disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Lancet Neurol. 14(7), 693–701 (2015)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of GranadaGranadaSpain
  2. 2.Hospital Universitario Central de AsturiasOviedoSpain

Personalised recommendations